Evidence map›Paper›PMID 35900792›Full record

ReviewEndocrine connections2022

The chance of transition: strategies for multidisciplinary collaboration.

J Gebauer, R Skinner, R Haupt, L Kremer, H van der Pal, G Michel, G T Armstrong, M M Hudson, L Hjorth, H Lehnert and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Endocrine connections, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 10 institutions in 8 countries.

J GebauerDepartment of Internal Medicine I, University Hospital of Schleswig-Holstein, Campus Luebeck and Institute for Endocrinology and Diabetes, University of Luebeck, Luebeck, Germany.ORCID 0000-0003-4428-8010
R SkinnerDepartment of Paediatric and Adolescent Haematology and Oncology and Children's BMT Unit, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, and Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
R HauptDOPO Clinic, Department of Hematology/Oncolgy, IRCCS Istituto Giannina Gaslini, Genova, Italy.
L KremerPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
H van der PalPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
G MichelDepartment of Health Sciences and Medicine, University of Lucerne, Luzern, Switzerland.
G T ArmstrongDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
M M HudsonDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
L HjorthDepartment of Clinical Sciences Lund, Paediatrics, Lund University, Skane University Hospital, Lund, Sweden.
H LehnertParis Lodron University of Salzburg, Salzburg, Austria.
T LangerPediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
St. Jude Children's Research Hospital · USEmma Kinderziekenhuis · NLIstituto Giannina Gaslini · ITLund University · SENewcastle upon Tyne Hospitals NHS Foundation Trust · GBPrincess Máxima Center · NLUniversity Hospital Schleswig-Holstein · DEUniversity of Lübeck · DEUniversity of Lucerne · CHUniversity of Salzburg · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many long-term childhood cancer survivors suffer from treatment-related late effects, which may occur in any organ and include a wide spectrum of conditions. Long-term follow-up (LTFU) is recommended to facilitate early diagnosis and to ensure better health outcomes. Due to the heterogeneity of these sequelae, different specialists work together in the diagnosis and treatment of these conditions. Experts from both pediatric and internal medicine are involved in age-appropriate care by providing a transition process. Hence, LTFU of childhood cancer survivors is a prototypic example of multidisciplinary care for patients with complex needs treated in a specialized setting. International collaborations of healthcare professionals and scientists involved in LTFU of childhood cancer survivors, such as the International Guideline Harmonization Group, compile surveillance recommendations that can be clinically adopted all over the world. These global networks of clinicians and researchers make a joint effort to address gaps in knowledge, increase visibility and awareness of cancer survivorship and provide an excellent example of how progress in clinical care and scientific research may be achieved by international and multidisciplinary collaboration.

Indexed as

childhood cancer survivorsinternational collaborationlate effectstransition

Identifiers

PMID35900792
PMCPMC9422248
OpenAlexW4286509639

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.